D. E. Shaw & Co., Inc. Y M Abs Therapeutics, Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 787,536 shares of YMAB stock, worth $8.77 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

787,536

Holding current value

$8.77 Million

% of portfolio

0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$9.95 - $15.39 $1.38 Million - $2.14 Million	-138,921 Reduced 14.99%	787,536 $10.3 Million
Q2 2024 Aug 14, 2024	SELL	$11.6 - $17.25 $1.64 Million - $2.44 Million	-141,702 Reduced 13.27%	926,457 $11.2 Million
Q1 2024 May 15, 2024	SELL	$6.57 - $18.69 $1.68 Million - $4.78 Million	-255,621 Reduced 19.31%	1,068,159 $17.4 Million
Q4 2023 Feb 14, 2024	SELL	$4.88 - $7.42 $124,098 - $188,690	-25,430 Reduced 1.88%	1,323,780 $9.03 Million
Q3 2023 Nov 14, 2023	BUY	$4.86 - $7.23 $358,731 - $533,667	73,813 Added 5.79%	1,349,210 $7.35 Million
Q2 2023 Aug 14, 2023	BUY	$5.68 - $10.34 $2.75 Million - $5.01 Million	484,441 Added 61.25%	1,275,397 $8.66 Million
Q1 2023 May 15, 2023	BUY	$2.83 - $5.11 $912,086 - $1.65 Million	322,292 Added 68.77%	790,956 $3.96 Million
Q4 2022 Feb 14, 2023	BUY	$3.0 - $15.17 $1.06 Million - $5.36 Million	353,174 Added 305.8%	468,664 $2.29 Million
Q3 2022 Nov 14, 2022	BUY	$13.96 - $19.67 $1.03 Million - $1.46 Million	74,103 Added 179.05%	115,490 $1.67 Million
Q2 2022 Aug 15, 2022	SELL	$8.22 - $15.13 $799,559 - $1.47 Million	-97,270 Reduced 70.15%	41,387 $626,000
Q1 2022 May 16, 2022	BUY	$6.55 - $17.42 $908,203 - $2.42 Million	138,657 New	138,657 $1.65 Million
Q3 2021 Nov 15, 2021	SELL	$27.47 - $37.31 $1.07 Million - $1.46 Million	-39,083 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$25.45 - $37.64 $1.05 Million - $1.56 Million	-41,382 Reduced 51.43%	39,083 $1.32 Million
Q1 2021 May 17, 2021	BUY	$29.16 - $51.96 $741,305 - $1.32 Million	25,422 Added 46.19%	80,465 $2.43 Million
Q4 2020 Feb 16, 2021	BUY	$37.86 - $54.26 $1.64 Million - $2.35 Million	43,303 Added 368.85%	55,043 $2.73 Million
Q3 2020 Nov 16, 2020	SELL	$35.13 - $43.62 $702,459 - $872,225	-19,996 Reduced 63.01%	11,740 $451,000
Q2 2020 Aug 14, 2020	BUY	$23.66 - $49.53 $265,843 - $556,519	11,236 Added 54.81%	31,736 $1.37 Million
Q1 2020 May 15, 2020	SELL	$14.39 - $35.8 $416,273 - $1.04 Million	-28,928 Reduced 58.53%	20,500 $535,000
Q4 2019 Feb 14, 2020	BUY	$23.81 - $33.78 $1.18 Million - $1.67 Million	49,428 New	49,428 $1.55 Million

Others Institutions Holding YMAB

# of Institutions

106

Shares Held

24.5M

Call Options Held

40.3K

Put Options Held

400

View Full List

About Y-mAbs Therapeutics, Inc.

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $487M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

More about YMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account